Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-29a' Or cancer = '' Total: 45 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-29a acute myeloid leukemia up microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
hsa-mir-29a acute myeloid leukemia down MicroRNA29a regulates the expression of the nuclear oncogene Ski.
hsa-mir-29a breast cancer up Next-generation sequencing of microRNAs for breast cancer detection.
hsa-mir-29a mir-29 breast cancer up microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
hsa-mir-29a breast cancer up Mir-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1.
hsa-mir-29a breast cancer down MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.
hsa-mir-29a cervical squamous cell carcinoma down Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
hsa-mir-29a cholangiocarcinoma up Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.
hsa-mir-29a colon cancer down miRNA-29a inhibits colon cancer growth by regulation of the PTEN/Akt/GSK3? and Wnt/?-catenin signaling pathways.
hsa-mir-29a colorectal cancer up microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.
hsa-mir-29a colorectal cancer up MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.
hsa-mir-29a colorectal cancer up Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
hsa-mir-29a ependymoma up Identification of microRNA signature in different pediatric brain tumors.
hsa-mir-29a mir-29 gastric cancer down Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.
hsa-mir-29a gastric cancer down MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.
hsa-mir-29a gastric cancer down MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
hsa-mir-29a gastric cancer down Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
hsa-mir-29a gastric cancer down miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.
hsa-mir-29a gastric cancer down MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells.
hsa-mir-29a mir-29 gastric cancer down Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.
hsa-mir-29a glioma down MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling.
hsa-mir-29a mir-29 head and neck squamous cell carcinoma down Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
hsa-mir-29a mir-29 hepatocellular carcinoma down Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
hsa-mir-29a mir-29 hepatocellular carcinoma down Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
hsa-mir-29a hepatocellular carcinoma down miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
hsa-mir-29a hepatocellular carcinoma down microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
hsa-mir-29a hepatocellular carcinoma down MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
hsa-mir-29a mir-29 hepatocellular carcinoma down Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a mir-29 hepatocellular carcinoma down Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.
hsa-mir-29a lung cancer down Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
hsa-mir-29a lung cancer down MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.
hsa-mir-29a mantle cell lymphoma down microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
hsa-mir-29a mir-29 mesenchymal cancer down miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.
hsa-mir-29a monocytic leukemia down Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.
hsa-mir-29a neuroblastoma down Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
hsa-mir-29a non-small cell lung cancer down Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
hsa-mir-29a non-small cell lung cancer down MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
hsa-mir-29a oral squamous cell carcinoma down MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.
hsa-mir-29a mir-29 pancreatic cancer down Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.
hsa-mir-29a pancreatic cancer up MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.
hsa-mir-29a papillary thyroid carcinoma down miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
hsa-mir-29a retinoblastoma down miR-29a inhibits human retinoblastoma progression by targeting STAT3.
hsa-mir-29a-3p gastric cancer down Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
hsa-mir-29a-3p hepatocellular carcinoma down miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.
hsa-mir-29a-5p endometrial cancer down MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.